Literature DB >> 9598511

Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma.

S Conrad1, M Graefen, U Pichlmeier, R P Henke, P G Hammerer, H Huland.   

Abstract

PURPOSE: An algorithm including the results of systematic sextant biopsies was statistically developed and evaluated to predict the probability of pelvic lymph node metastases in patients with clinically localized carcinoma of the prostate.
MATERIALS AND METHODS: Clinical stage, serum prostate specific antigen concentration, Gleason score, number of positive biopsies, number of biopsies containing any Gleason grade 4 or 5 cancer and number of biopsies predominated by Gleason grade 4 or 5 cancer were recorded in 345 patients undergoing pelvic lymph node dissection and correlated with the incidence of lymph node metastases. Multivariate logistic regression, and classification and regression trees analyses were performed.
RESULTS: In univariate analysis all variables had a statistically significant influence on lymph node status. Logistic regression showed that the amount and distribution of undifferentiated Gleason grade 4 and 5 cancer in the biopsies were the best predictors of lymphatic spread followed by serum prostate specific antigen. Classification and regression trees analysis classified 79.9% of patients who had 3 or fewer biopsies with Gleason grade 4 or 5 cancer and no biopsies predominated by undifferentiated cancer as a low risk group. In this group positive lymph nodes occurred in only 2.2% (95% confidence interval 0.8 to 4.7%).
CONCLUSIONS: Including the results of systematic sextant biopsies substantially enhances the predictive accuracy of algorithms that define the probability of lymph node metastases in prostatic cancer. Patients thus defined as having no lymphatic spread could potentially be spared pelvic lymph node dissection before definitive local treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9598511

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.

Authors:  Matthew S Katz; Jason A Efstathiou; Anthony V D'Amico; Michael W Kattan; Martin G Sanda; Paul L Nguyen; Matthew R Smith; Peter R Carroll; Anthony L Zietman
Journal:  BJU Int       Date:  2010-03-15       Impact factor: 5.588

2.  The importance of pelvic lymph node dissection in men with clinically localized prostate cancer.

Authors:  Mohamad E Allaf; Alan W Partin; H Ballentine Carter
Journal:  Rev Urol       Date:  2006

3.  Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.

Authors:  Felix K-H Chun; Markus Graefen; Mario Zacharias; Alexander Haese; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Pierre I Karakiewicz; Hartwig Huland
Journal:  World J Urol       Date:  2006-02-28       Impact factor: 4.226

4.  Prostate cancer: epidemiology and screening.

Authors:  M K Brawer; E D Crawford; J Fowler; M S Lucia; F H Schröeder
Journal:  Rev Urol       Date:  2000

5.  Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.

Authors:  Ramzi Rajab; Gabrielle Fisher; Michael W Kattan; Christopher S Foster; Tim Oliver; Henrik Møller; Victor Reuter; Peter Scardino; Jack Cuzick; Daniel M Berney
Journal:  Virchows Arch       Date:  2010-09-09       Impact factor: 4.064

6.  Role of pelvic lymph node dissection in prostate cancer treatment.

Authors:  Jae Young Joung; In-Chang Cho; Kang Hyun Lee
Journal:  Korean J Urol       Date:  2011-07-24

Review 7.  Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy.

Authors:  Roger Li; Firas G Petros; Janet B Kukreja; Stephen B Williams; John W Davis
Journal:  Investig Clin Urol       Date:  2016-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.